AstraZeneca
AZN
AZN
449 hedge funds and large institutions have $8.63B invested in AstraZeneca in 2016 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 113 increasing their positions, 161 reducing their positions, and 73 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
449
Holders Change
+1
Holders Change %
+0.22%
% of All Funds
11.24%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.15%
New
78
Increased
113
Reduced
161
Closed
73
Calls
$211M
Puts
$76.1M
Net Calls
+$135M
Net Calls Change
+$30.8M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$252M |
| 2 |
Primecap Management
Pasadena,
California
|
+$237M |
| 3 |
Dodge & Cox
San Francisco,
California
|
+$203M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$40.4M |
| 5 |
Jennison Associates
New York
|
+$39.3M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$434M |
| 2 |
CI
Cambiar Investors
Denver,
Colorado
|
-$148M |
| 3 |
ClearBridge Investments
New York
|
-$126M |
| 4 |
Renaissance Technologies
New York
|
-$118M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$92.5M |
